USPTO serial 98297986
RISKREVEAL
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- LINCOSKI JR, JOHN T
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with RISKREVEAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $150
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Nashville, TN, US
Nashville, TN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DAVID R. STEVENS
DAVID R. STEVENS STEVENS LAW GROUP1754 TECHNOLOGY DRIVE SUITE 226SAN JOSE, CA 95110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical diagnostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Formalin fixed, paraffin embedded (FFPE) diagnostic kits comprised of medical diagnostic reagents and assays for testing of tumor tissue for use in risk segregation and managing disease treatment, namely, cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 8, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 7, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 7, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 7, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 6, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 5, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 5, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 5, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 3, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 2, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 2, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 1, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 26, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 26, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 31, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 31, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 31, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 3, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 3, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 3, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 1, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 24, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 7, 2023 | NWAP | NEW APPLICATION ENTERED | — |